FDA Clearance Tracker · K253985
INNOVANCE® D-Dimer 2.0 (SMN 10873803)
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 11, 2026
Substantially Equivalent
Time to decision
242 days
Received Dec 12, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K253985
- Device name
- INNOVANCE® D-Dimer 2.0 (SMN 10873803)
- Applicant location
- Marburg, DE
- Received
- Dec 12, 2025
- Decided
- Aug 11, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 864.7320
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DAP. The earliest in FDA's data is K862156, decided Sep 16, 1986.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K253985
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Siemens Healthcare Diagnostic Products GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- INNOVANCE Antithrombin510(k)
K242952 · Decided Mar 28, 2025 · 184 days after receipt
Device type: Antithrombin Iii Quantitation (JBQ) · Laboratory Medicine & Pathology
- CardioPhase® hsCRP510(k)
K232624 · Decided Nov 27, 2023 · 90 days after receipt
Device type: System, Test, C-Reactive Protein (DCN) · Laboratory Medicine & Pathology
K172286 · Decided Dec 18, 2017 · 143 days after receipt
Device type: System, Multipurpose For In Vitro Coagulation Studies (JPA) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.